- The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?
-
Coleman RL
- KMID: 2526290
- J Gynecol Oncol.
- 2021 Jan;32(1):e210.
- doi: 10.3802/jgo.2021.32.e20
-
- CITED
-
- Close
- SHARE
-
- Close
- The current status of laparoscopic and robotic para-aortic lymphadenectomy in gynecologic cancer surgery
-
Ind T
- KMID: 2526291
- J Gynecol Oncol.
- 2021 Jan;32(1):e28.
- doi: 10.3802/jgo.2021.32.e28
-
- CITED
-
- Close
- SHARE
-
- Close
- Why was GOG-0213 a negative trial?
-
Ehmann S, Zivanovic O, Chi DS
- KMID: 2526288
- J Gynecol Oncol.
- 2021 Jan;32(1):e19.
- doi: 10.3802/jgo.2021.32.e19
-
- CITED
-
- Close
- SHARE
-
- Close
- The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
-
Bartl T, Bekos C, Postl M, Alexander R, Polterauer S, Stefanie A, Richard S
- KMID: 2526289
- J Gynecol Oncol.
- 2021 Jan;32(1):e1.
- doi: 10.3802/jgo.2021.32.e1
Objective: To assess the prognostic value of the systemic immune-inflammation index (SII) in patients with vulvar cancer. Methods: Data of 130 consecutive patients who underwent primary surgical resection for vulvar cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- The extent of aortic lymphadenectomy in locally advanced cervical cancer impacts on survival
-
Llueca A, Escrig J, Gil-Moreno A, Benito V, Hernández A, Díaz-Feijoo B, on behalf of Spain-Gynecologic Oncology Group (GOG) Working Group
- KMID: 2526294
- J Gynecol Oncol.
- 2021 Jan;32(1):e4.
- doi: 10.3802/jgo.2021.32.e4
Objective: The prognostic impact of surgical paraaortic staging remains unclear in patients with locally advanced cervical cancer (LACC). The objective of our study was to evaluate the results of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Time for enhancing government-led primary prevention of cervical cancer
-
Min KJ, Suh DH, Baba T, Chen X, Kim JW, Kobayashi Y, Kwon J, Lim MC, Lee JY, Nagase S, Park JY, Tangjitgamol S, Watari H
- KMID: 2526286
- J Gynecol Oncol.
- 2021 Jan;32(1):e12.
- doi: 10.3802/jgo.2021.32.e12
-
- CITED
-
- Close
- SHARE
-
- Close
- Total laparoscopic vs. conventional open abdominal nerve-sparing radical hysterectomy: clinical, surgical, oncological and functional outcomes in 301 patients with cervical cancer
-
Ceccaroni M, Roviglione G, Malzoni M, Cosentino F, Spagnolo E, Clarizia R, Casadio P, Seracchioli R, Ghezzi F, Mautone D, Bruni F, Uccella S
- KMID: 2526285
- J Gynecol Oncol.
- 2021 Jan;32(1):e10.
- doi: 10.3802/jgo.2021.32.e10
Objective: Total laparoscopic nerve-sparing radical hysterectomy (TL-NSRH) has been considered a promising approach, however, surgical, clinical, oncological and functional outcomes have not been systematically addressed. We present a large retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m2 versus 40 mg/m2 in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial
-
Motohashi T, Yabuno A, Michimae H, Ohishi T, Nonaka M, Takano M, Nishio S, Fujiwara H, Keiichi K, Kondo E, Sugiyama T, Tabata T
- KMID: 2526299
- J Gynecol Oncol.
- 2021 Jan;32(1):e9.
- doi: 10.3802/jgo.2021.32.e9
Objective: The standard dose for pegylated liposomal doxorubicin (PLD) is 50 mg/m2 every 4 weeks. While 40 mg/m2 has recently been used in clinical practice, evidence supporting this use remains... -
- CITED
-
- Close
- SHARE
-
- Close
- A new technique of laparoscopic para-aortic lymphadenectomy optimizes perioperative outcome
-
Lin Y, He L, Mei Y
- KMID: 2526292
- J Gynecol Oncol.
- 2021 Jan;32(1):e2.
- doi: 10.3802/jgo.2021.32.e2
Objective: The aim of the present study was to introduce a new technique for laparoscopic para-aortic lymphadenectomy (PAL): an invented retroperitoneum suspension needle combined with modified trocar placement. Methods: This prospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trial
-
Tate S, Nishikimi K, Matsuoka A, Otsuka S, Kato K, Takahashi Y, Shozu M
- KMID: 2526298
- J Gynecol Oncol.
- 2021 Jan;32(1):e8.
- doi: 10.3802/jgo.2021.32.e8
Objective: We investigated the efficacy and toxicity of tailored-dose chemotherapy with gemcitabine and irinotecan for platinum-refractory/resistant ovarian or primary peritoneal cancer. Methods: We enrolled patients with ovarian or primary peritoneal cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Robot-assisted extraperitoneal paraaortic lymphadenectomy (RAePAL) performed with the bipolar cutting method
-
Yanai S, Kanno K, Aiko K, Ando M
- KMID: 2526296
- J Gynecol Oncol.
- 2021 Jan;32(1):e6.
- doi: 10.3802/jgo.2021.32.e6
Objective: In comparison with laparoscopic transperitoneal para-aortic lymphadenectomy, the advantages of laparoscopic extraperitoneal para-aortic lymphadenectomy (ePAL) are that the operative field is not obstructed by bowel and the Trendelenburg position... -
- CITED
-
- Close
- SHARE
-
- Close
- Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control
-
Buderath P, Rusch P, Mach P, Kimmig R
- KMID: 2526297
- J Gynecol Oncol.
- 2021 Jan;32(1):e7.
- doi: 10.3802/jgo.2021.32.e7
Objective: Peritoneal mesometrial resection (PMMR) plus targeted compartmental lymphadenectomy (TCL) aims at removal of the locoregional cancer field in endometrial cancer (EC). Optimal locoregional control without adjuvant radiotherapy and acceptable... -
- CITED
-
- Close
- SHARE
-
- Close
- Conditional relative survival of cervical cancer: a Korean National Cancer Registry Study
-
Shin DW, Bae J, Ha J, Jung KW
- KMID: 2526295
- J Gynecol Oncol.
- 2021 Jan;32(1):e5.
- doi: 10.3802/jgo.2021.32.e5
Objective: Conditional relative survival (CRS) considers changes in prognosis over time and may offer more useful estimates for survivors. We aimed to investigate CRS among patients with cervical cancer stratified... -
- CITED
-
- Close
- SHARE
-
- Close
- Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013
-
Bui CN, Choi E, Suh M, Jun JK, Jung KW, Lim MC, Choi KS
- KMID: 2526287
- J Gynecol Oncol.
- 2021 Jan;32(1):e14.
- doi: 10.3802/jgo.2021.32.e14
Objective: This study sought to examine changes in trends for quality indicators of the population-based Korean National Cancer Screening Program (KNCSP) for cervical cancer from years 2005 to 2013. Methods: Our... -
- CITED
-
- Close
- SHARE
-
- Close
- Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma
-
Jung US, Min KW, Kim DH, Kwon MJ, Park H, Jang HS
- KMID: 2526293
- J Gynecol Oncol.
- 2021 Jan;32(1):e3.
- doi: 10.3802/jgo.2021.32.e3
Objective: AT-rich interactive domain 1A (ARID1A) plays an important role as a tumor suppressor gene in ovarian clear cell carcinoma (OCCC), but the clinical application of ARID1A remains unclear. The... -
- CITED
-
- Close
- SHARE
-
- Close
